Literature DB >> 29559602

[Clinical efficacy of ozonated oil in the treatment of psoriasis vulgaris].

Lina Tan1, Jian Huang1, Jing Lu1, Jianyun Lu1.   

Abstract

OBJECTIVE: To compare the efficacy and safety between ozonated oil and compound flumethasone ointment in the treatment of psoriasis vulgaris.

Methods: A left/right self-controlled, parallel group study was conducted. Forty patients with stable psoriasis vulgaris were enrolled in the study, whose lesions were symmetrical and involvement areas were <30% body surface. The patients were divided into 2 groups. Patients with left lesions served as a test group were treated daily for ozonated oil twice, and patients with right lesions served as a control group were treated daily for compound flumetasone ointment twice. The patients in the 2 groups were treated for 4 weeks. The clinical efficacy and safety were observed at 1, 2 and 4 weeks after the treatment.

Results: After 1 week treatment, the effective rates of the test group and the control group were 60.58% and 72.28%, respectively, with significant difference between them (P<0.05). At 2 weeks and 4 weeks after the treatment, the efficacy in the test group was similar to that in the control group. The effective rates in the test group and the control group were 69.84% and 70.25% after 2 weeks, respectively, 70.88% and 71.23% after 4 weeks, respectively. There was no significant difference between the 2 groups (P<0.05). In addition, the reflectance confocal microscope results in both the test group and the control group after 4 weeks showed that the epidermis was approximately normal. There were few inflammatory cells infiltration in the dermal papilla, and the inflammatory cells infiltration was significantly reduced after treatment.

Conclusion: Ozonated oil treatment for stable psoriasis is safe and effective, and its efficacy is equivalent to the effect of glucocorticoid topical preparations.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29559602     DOI: 10.11817/j.issn.1672-7347.2018.02.012

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  4 in total

1.  Ozonated autohemotherapy elevates PPAR-γ expression in CD4+ T cells and serum HDL-C levels, a potential immunomodulatory mechanism for treatment of psoriasis.

Authors:  Jinrong Zeng; Zhen Tang; Yuezhong Zhang; Xiaoliang Tong; Jianhua Dou; Lihua Gao; Shu Ding; Jianyun Lu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

Review 2.  Ozone Therapy for Dermatological Conditions: A Systematic Review.

Authors:  Débora Aparecida Oliveira Modena; Rafael de Castro Ferreira; Patricia Meyer Froes; Katya Cristina Rocha
Journal:  J Clin Aesthet Dermatol       Date:  2022-05

3.  Ozone therapy promotes the differentiation of basal keratinocytes via increasing Tp63-mediated transcription of KRT10 to improve psoriasis.

Authors:  Lihua Gao; Jianhua Dou; Bo Zhang; Jinrong Zeng; Qingmei Cheng; Li Lei; Lina Tan; Qinghai Zeng; Shu Ding; Aiyuan Guo; Haipeng Cheng; Caifeng Yang; Ziqiang Luo; Jianyun Lu
Journal:  J Cell Mol Med       Date:  2020-03-13       Impact factor: 5.310

4.  Ozone Therapy Attenuates NF-κB-Mediated Local Inflammatory Response and Activation of Th17 Cells in Treatment for Psoriasis.

Authors:  Jinrong Zeng; Li Lei; Qinghai Zeng; Yuying Yao; Yuqing Wu; Qinxuan Li; Lihua Gao; Hongjiao Du; Yajie Xie; Jinhua Huang; Wenbin Tan; Jianyun Lu
Journal:  Int J Biol Sci       Date:  2020-04-06       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.